7.09
                                            Schlusskurs vom Vortag:
              $7.09
            Offen:
              $7.36
            24-Stunden-Volumen:
                66,054
            Relative Volume:
              0.33
            Marktkapitalisierung:
                $48.79M
            Einnahmen:
              -
            Nettoeinkommen (Verlust:
              $-26.92M
            KGV:
              -13.90
            EPS:
                -0.51
            Netto-Cashflow:
                $-18.92M
            1W Leistung:
              -21.48%
            1M Leistung:
              -32.28%
            6M Leistung:
                -5.84%
            1J Leistung:
              -72.93%
            Cel-Sci Corp. Stock (CVM) Company Profile
Firmenname
                  
                      Cel-Sci Corp.
                    
                Sektor
                  Branche
                  Telefon
                  
                      703-506-9460
                    
                Adresse
                  
                      8229 Boone Boulevard, Suite 802, Vienna, VA
                    
                Vergleichen Sie CVM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                CVM
                            
                             
                        Cel-Sci Corp. 
                           | 
                    7.09 | 56.67M | 0 | -26.92M | -18.92M | -0.51 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Cel-Sci Corp. Stock (CVM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2020-01-13 | Eingeleitet | H.C. Wainwright | Buy | 
| 2015-03-02 | Eingeleitet | Dawson James | Buy | 
Cel-Sci Corp. Aktie (CVM) Neueste Nachrichten
Why Cel Sci Corporation stock is upgraded to buyEarnings Beat & Weekly Watchlist of Top Performers - newser.com
Why Cel Sci Corporation stock is trending on social mediaJuly 2025 Rallies & AI Driven Stock Reports - newser.com
Can Cel Sci Corporation stock deliver double digit returns2025 Geopolitical Influence & Intraday High Probability Alerts - newser.com
What insider purchases suggest about CEL SCI Corporation (LSR) stockEarnings Overview Summary & Fast Momentum Stock Entry Tips - newser.com
Will CEL SCI Corporation stock benefit from upcoming earnings reports2025 Winners & Losers & Free Safe Capital Growth Stock Tips - newser.com
Published on: 2025-11-03 02:04:39 - newser.com
Advanced analytics toolkit walkthrough for CEL SCI CorporationTrade Analysis Report & Community Consensus Trade Alerts - newser.com
Published on: 2025-11-02 22:20:43 - newser.com
How Cel Sci Corporation stock performs in easing cyclesWatch List & High Accuracy Swing Entry Alerts - newser.com
Does CEL SCI Corporation qualify in momentum factor screeningTrade Exit Report & Technical Entry and Exit Alerts - newser.com
Using AI based signals to follow CEL SCI CorporationJuly 2025 Technicals & Fast Moving Trade Plans - newser.com
Will CEL SCI Corporation (LSR) stock gain from lower interest rates2025 Volatility Report & Safe Capital Growth Plans - newser.com
What risks investors should watch in CEL SCI Corporation stockNew Guidance & High Accuracy Trade Signal Alerts - newser.com
Can Cel Sci Corporation stock test all time highs2025 Top Decliners & AI Driven Price Predictions - newser.com
How CEL SCI Corporation (LSR) stock responds to job market shiftsPrice Action & Expert Curated Trade Ideas - newser.com
Why CEL SCI Corporation stock is trending among retail traders2025 Pullback Review & AI Driven Price Forecasts - newser.com
What recovery options are there for CEL SCI Corporation2025 Price Targets & Expert Curated Trade Setup Alerts - newser.com
Will CEL SCI Corporation (LSR) stock split increase liquidityOptions Play & Verified Momentum Stock Watchlist - newser.com
Can CEL SCI Corporation (LSR) stock reach $200 price targetJuly 2025 Chart Watch & Fast Entry High Yield Tips - fcp.pa.gov.br
Is CEL SCI Corporation stock a top momentum playJuly 2025 Highlights & Free Long-Term Investment Growth Plans - newser.com
Will CEL SCI Corporation (LSR) stock deliver compounding returnsJuly 2025 Decliners & Weekly High Potential Stock Alerts - newser.com
Using data filters to optimize entry into CEL SCI CorporationJuly 2025 Sector Moves & Risk Controlled Stock Alerts - newser.com
How CEL SCI Corporation stock reacts to bond yieldsWeekly Investment Recap & Risk Managed Investment Strategies - Trung tâm Dự báo KTTV quốc gia
Finanzdaten der Cel-Sci Corp.-Aktie (CVM)
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):